Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 114

Gene-editing therapy shows early success in fighting advanced gastrointestinal cancers

Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. The results, recently published in The Lancet Oncology, show encouraging signs of the safety and potential effectiveness of the treatment.

“Despite many advances in understanding the genomic drivers and other factors causing cancer, with few exceptions, stage IV remains a largely incurable disease,” said Emil Lou, MD, Ph.D., a gastrointestinal oncologist with the University of Minnesota Medical School, Masonic Cancer Center and M Health Fairview, and clinical principal investigator for the trial. “This trial brings a new approach from our research labs into the clinic and shows potential for improving outcomes in patients with late-stage disease.”

In the study, researchers used CRISPR/Cas9 gene-editing to modify a type of immune cell called tumor-infiltrating lymphocytes (TILs). By deactivating a gene called CISH, the researchers found that modified TILs were better able to recognize and attack .

AI identifies PHGDH as amyloid pathology driver in Alzheimer’s disease

Insomnia, depression, and anxiety are the most common mental disorders. Treatments are often only moderately effective, with many people experiencing returning symptoms. This is why it is crucial to find new leads for treatments. Notably, these disorders overlap a lot, often occurring together. Could there be a shared brain mechanism behind this phenomenon?

Siemon de Lange, Elleke Tissink, and Eus van Someren, together with their colleagues from the Vrije Universiteit Amsterdam, investigated brain scans of more than 40,000 participants from the UK Biobank. The research is published in the journal Nature Mental Health.

Tissink says, “In our lab, we explore the similarities and differences between , anxiety, and depression. Everyone looks at this from a : some mainly look at genetics and in this study, we look at brain scans. What aspects are shared between the disorders, and what is unique to each one?”

Gut microbes release cancer-fighting bile acids that block hormone signals

Bacteria naturally present in the human intestine (known as the gut microbiota) can transform cholesterol-derived bile acids into powerful metabolites that strengthen anti-cancer immunity by blocking androgen signaling, according to a preclinical study led by Weill Cornell Medicine investigators. The study was published on April 15 in Cell.

“I was very surprised by our findings. As far as I know, no one has previously discovered molecules like these bile acids that can interact with the androgen receptor in this way,” said co-senior author Dr. Chun-Jun Guo, an associate professor of immunology in medicine in the Division of Gastroenterology and Hepatology and a scientist at the Jill Roberts Institute for Research in Inflammatory Bowel Disease at Weill Cornell Medicine.

Dr. David Artis, director of the Jill Roberts Institute and the Friedman Center for Nutrition and Inflammation and the Michael Kors Professor in Immunology, and Dr. Nicholas Collins, assistant professor of immunology in medicine, both at Weill Cornell Medicine, are co-senior authors of the study. Drs. Wen-Bing Jin, formerly a postdoctoral associate, and Leyi Xiao, a current postdoctoral associate in Dr. Guo’s lab, are the co-first authors of the study.

Founder interview: Dr. Emil Kendziorra, Founder & CEO at Tomorrow Biostasis

In our Founder Interview series, we highlight the brightest minds in preventive health, wellness, and longevity. In Episode 6, we’re honored to feature Dr. Emil Kenziorra, founder and CEO at Tomorrow Biostasis —one of the world-leading human cryopreservation experts.

Tell us a little about yourself and your current venture

Doctor and researcher by training, entrepreneur by trade. Longevity has always been my motivation, with a focus on maximal life span extension. I’m running Tomorrow.bio and the non-profit European Biostasis Foundation to push human cryopreservation forward.

Betavoltaic cell with perovskite-radioactive isotope combo can power long-term applications

A research team has developed the world’s first next-generation betavoltaic cell by directly connecting a radioactive isotope electrode to a perovskite absorber layer. By embedding carbon-14-based quantum dots into the electrode and enhancing the perovskite absorber layer’s crystallinity, the team achieved both stable power output and high energy conversion efficiency.

The work is published in the journal Chemical Communications. The team was led by Professor Su-Il In of the Department of Energy Science & Engineering at DGIST.

The newly developed technology offers a stable, long-term power supply without the need for recharging, making it a promising next-generation energy solution for fields requiring long-term power autonomy, such as , , and military applications.

Microbubble dynamics in boiling water enable precision fluid manipulation

A watched pot never boils, goes the old saying, but many of us have at least kept an eye on the pot, waiting for the bubbling to start. It’s satisfying to finally see the rolling boil, behind which complex physical mechanisms are at play.

When this happens, the that form continuously change in shape and size. These dynamic movements influence the surrounding fluid flow, thereby affecting the efficiency of heat transfer from the to the water.

Manipulating small amounts of liquid at high speeds and frequencies is essential for processing large numbers of samples in medical and chemical fields, such as in cell sorting. Microbubble vibrations can create flows and sound waves, aiding in liquid manipulation. However, the and interactions of multiple bubbles is poorly understood, so their applications have been limited.